Jones Financial Companies
MAIA icon

Jones Financial Companies’s MAIA Biotechnology MAIA Stock Holding History

Jones Financial Companies’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$299 Hold
228
– – ﹤0.01% 4559
2025
Q4 		$349 Hold
228
– – ﹤0.01% 4214
2025
Q3 		$369 Hold
228
– – ﹤0.01% 4076
2025
Q2 		$404 Hold
228
– – ﹤0.01% 3836
2025
Q1 		$369 Buy
+228
New +$422 ﹤0.01% 3548

Other funds holding MAIA

SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jones Financial Companies's MAIA Position: Q1 2026 in Review

Jones Financial Companies held its MAIA Biotechnology (MAIA) position steady in Q1 2026 at 228 shares worth $299. The position accounts for ﹤0.01% of the portfolio, ranked #4559.

Jones Financial Companies first reported a position in MAIA in Q1 2025 and has held it in 5 quarters since. The position peaked at $404 in Q2 2025. 33 funds tracked by Wall St. Rank hold MAIA as of Q1 2026.

  • Jones Financial Companies held 228 shares of MAIA Biotechnology worth $299 as of Q1 2026.
  • Jones Financial Companies left its MAIA Biotechnology share count unchanged in Q1 2026.
  • MAIA Biotechnology made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #4559 holding.
  • Jones Financial Companies first reported a position in MAIA Biotechnology in Q1 2025 and has held it in 5 quarters since.
  • Jones Financial Companies's MAIA Biotechnology position peaked at $404 in Q2 2025.
  • 33 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.